ArsenalBio
Engineering Hope®
- Headquarters
- San Francisco, California
- Employees
- 201–500
- Founded
- 2019
- Business Model
- B2B
- Website
- arsenalbio.com
- Total Funding
- $955.0M
- Last Round
- $325.0M Series CSep 2024
About
ArsenalBio is a clinical-stage programmable cell therapy company engineering advanced CAR T-cell therapies for solid tumors. Using a synthetic biology toolkit, the company genetically programs patients' T cells to eradicate solid tumors and has an ongoing multi-program collaboration with Bristol Myers Squibb to advance next-generation T-cell therapies.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account